No abstract available
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Biological Availability
-
Dose-Response Relationship, Drug
-
Female
-
Gene Expression Regulation, Leukemic / drug effects
-
Genes, abl / genetics
-
Humans
-
Imatinib Mesylate / analysis
-
Imatinib Mesylate / blood
-
Imatinib Mesylate / pharmacokinetics*
-
Imatinib Mesylate / therapeutic use
-
Intracellular Space / chemistry
-
Intracellular Space / metabolism*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / diagnosis*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / metabolism*
-
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
-
Male
-
Octamer Transcription Factor-1 / genetics
-
Octamer Transcription Factor-1 / metabolism
-
Predictive Value of Tests
-
Prognosis
-
Sensitivity and Specificity
-
Treatment Outcome
Substances
-
Octamer Transcription Factor-1
-
Imatinib Mesylate